In our results, therapeutic targets or biomarkers of neurological disorder and mental disorder, such as DRD1, DRD2, DRD4, HTR2A, PRL and ADRA2A, were assigned with high scores in both mirtazapine and pramipexole (Fig. 4a and b). This evidence concerns the gene DRD1 and nervous system disorder.